NUCLEOME THERAPEUTICS LIMITED
Research and experimental development on biotechnology
NUCLEOME THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
Nucleome Therapeutics Limited, Inventa Botley Road Oxford OX2 0HA United Kingdom
Full company profile for NUCLEOME THERAPEUTICS LIMITED (12109297), an active life sciences and medical technology company based in Oxford, United Kingdom. Incorporated 17 Jul 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2020–2024)
Cash in Bank
£12.29M
Net Assets
£23.03M
Total Liabilities
£1.31M
Turnover
£156.05k
Employees
44
Debt Ratio
5%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2024 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (5)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Oct 2022 | Series A |
| Investor 2 | Oct 2022 | Series A |
| Investor 3 | Oct 2022 | Series A |
See all 5 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Bauke Anninga | Director | Dutch | Netherlands | 21 Oct 2022 | Active |
| Emma Johnson | Director | British | United Kingdom | 2 Mar 2023 | Active |
| Fiona Caroline Maclaughlin | Director | British | England | 21 Oct 2022 | Active |
See all 13 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Oxford Science Enterprises Plc
United Kingdom
- Voting Rights 25 To 50 Percent
James Raymond Hughes
Ceased 29 Jul 2019
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
| Address | Tenure | Price Paid | Date Added |
|---|---|---|---|
Unit A, Inventa, Botley Road, Oxford (OX2 0HA) OXFORD | Leasehold | - | 9 Jan 2025 |
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 5 Mar 2026 | Capital | Allotment of shares (GBP 1,026.72031) on 3 Mar 2026 | |
| 4 Mar 2026 | Resolution | Resolutions | |
| 4 Mar 2026 | Capital | Capital Name Of Class Of Shares | |
| 24 Feb 2026 | Capital | Allotment of shares (GBP 1,026.61705) on 3 Feb 2026 | |
| 9 Feb 2026 | Capital | Allotment of shares (GBP 1,018.75984) on 20 Jan 2026 |
Allotment of shares (GBP 1,026.72031) on 3 Mar 2026
Resolutions
Capital Name Of Class Of Shares
Allotment of shares (GBP 1,026.61705) on 3 Feb 2026
Allotment of shares (GBP 1,018.75984) on 20 Jan 2026
Recent Activity
Latest Activity
Allotment of shares (GBP 1,026.72031) on 3 Mar 2026
1 months ago on 5 Mar 2026
Resolutions
2 months ago on 4 Mar 2026
Capital Name Of Class Of Shares
2 months ago on 4 Mar 2026
Allotment of shares (GBP 1,026.61705) on 3 Feb 2026
2 months ago on 24 Feb 2026
Allotment of shares (GBP 1,018.75984) on 20 Jan 2026
2 months ago on 9 Feb 2026